FIELD: chemistry.
SUBSTANCE: invention relates to a mixed complex metal compound containing calcium and manganese in the form of a complex with a formula I compound or a pharmaceutically acceptable salt thereof: formula I. In formula I the radicals have the following meanings: X is CH, each R1 independently represents -CH2COR5, R5 represents hydroxy, each R2 independently represents ZYR6, where Z represents C1-3alkylene group, Y represents a bond, R6 represents OR8 or OP(O)(OR8)R7, R7 represents hydroxy or an unsubstitutedC1-6alkyl or aminoalkyl group, R8 represents a hydrogen atom or a C1-6alkyl group, R3 represents an ethylene group, and each R4 independently represents hydrogen or C1-3alkyl. A pharmaceutical composition, a method of a mixed complex metal compound and a treatment method are also proposed.
EFFECT: improved treatment of pathological conditions caused by the presence of free radicals generated by oxygen.
26 cl, 35 dwg, 11 ex
Title |
Year |
Author |
Number |
KALMANGAFODIPIR, NEW CHEMICAL COMPOUND, AND OTHER MIXED COMPLEX COMPOUNDS WITH METALS, METHODS FOR PRODUCTION, COMPOSITIONS AND METHODS FOR TREATMENT |
2012 |
- Karlsson Jan Olof
- Reineke Karl
- Kurz Tino
- Andersson Rolf
- Hall Michael
- Mclaughlin Christina
- Jacobsson Sven
- Naesstroem Jacques
|
RU2765805C2 |
PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS IMPLYING APPLICATION OF COMBINATION OF COMPLEX COMPOUND OF MANGANESE AND COMPOUND IN FORM OTHER THAN MANGANESE COMPLEX |
2010 |
- Karlsson Jan-Olof
- Andersson Rol'F
|
RU2563825C2 |
COMPOUNDS FOR TREATING CANCER |
2008 |
- Karlsson Jan Olof G.
- Kurts Tino
- Andersson Rol'F
|
RU2491282C2 |
COMBINED THERAPY FOR CANCER TREATMENT |
2015 |
- Bao, Xingfeng
- Albu, Diana
- Woodall-Jappe, Mary
|
RU2708374C2 |
NOVEL ANTITUMOR COMPOUNDS |
2003 |
- Fehrklot Glinn Tomas
- Ehlises Mar'Jano
- Sasak Khalina
- Aviles Marin Pablo Manuehl'
- Kuehvas Marchante Marija Del' Karmen
|
RU2356908C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH ARGININE-DEPLETING AND IMMUNE-ONCOLOGICAL AGENTS |
2017 |
- Lowe, David
- Rowlinson, Scott, W.
- Alters, Susan
- Agnello, Giulia
|
RU2771313C2 |
COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE |
2018 |
- Abastado Jean-Pierre
- Amellal Nadia
- Bruno Alain
- Burbridge Michael Frank
- Cattan Valerie
- Leger Catherine
|
RU2778887C2 |
COMBINATION THERAPY USING CC CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE CHECKPOINT INHIBITORS |
2019 |
- Li, Shijie
- Mali, Venkat Reddy
- Singh, Rajinder
- Yang, Ju
- Zhang, Penglie
|
RU2810717C2 |
THERAPEUTIC USES OF ARSENIC AND POSSIBLE MECHANISMS OF ACTION |
2020 |
- Rieger, Francois
- Batteux, Frederic
|
RU2815051C2 |
COMBINED ANTICANCER THERAPY AND PHARMACEUTICAL COMPOSITIONS THEREFOR |
2005 |
- Boer Zhak Alen
- K'Javaroli Karlo
|
RU2396960C2 |